Amsterdam Molecular Therapeutics

Amsterdam Molecular Therapeutics is a privately held biotechnology holding company focused on licensing promising pharmaceutical and medical device technologies in the pre-clinical development stage, conducting proof-of-concept clinical (Phase II) studies on a virtual basis, and ultimately pursuing corporate partnerships and commercialization.